Literature DB >> 22221786

Endocrine complications in long-term survivors after allogeneic stem cell transplant.

Uma Gunasekaran1, Neena Agarwal, Madan H Jagasia, Shubhada M Jagasia.   

Abstract

As survival rates continue to increase after allogeneic stem cell transplant (allo-SCT), the associated long-term complications of transplant need to be taken into consideration. Here, we review the endocrine and metabolic complications associated with transplant survivors, including diabetes, dyslipidemia, hypertension, cardiovascular disease, hypogonadism, vitamin D deficiency, osteoporosis, thyroid disease, adrenal dysfunction, and pituitary disorders, and provide a brief summary of evaluation and treatment of these conditions.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22221786     DOI: 10.1053/j.seminhematol.2011.10.010

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  7 in total

1.  Existential challenges experienced by lymphoma survivors: Results from the 2010 LIVESTRONG Survey.

Authors:  Donna M Posluszny; Mary Amanda Dew; Ellen Beckjord; Dana H Bovbjerg; John E Schmidt; Carissa A Low; Amy Lowery; Stephanie A Nutt; Sarah R Arvey; Ruth Rechis
Journal:  J Health Psychol       Date:  2015-04-06

Review 2.  What do we need to know about allogeneic hematopoietic stem cell transplant survivors?

Authors:  C A Clark; M Savani; M Mohty; B N Savani
Journal:  Bone Marrow Transplant       Date:  2016-04-11       Impact factor: 5.483

Review 3.  Long-term follow-up after allogeneic stem cell transplantation.

Authors:  Inken Hilgendorf; Hildegard Greinix; Jörg P Halter; Anita Lawitschka; Hartmut Bertz; Daniel Wolff
Journal:  Dtsch Arztebl Int       Date:  2015-01-23       Impact factor: 5.594

4.  Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events.

Authors:  Priyanka A Pophali; Jeffrey K Klotz; Sawa Ito; Natasha A Jain; Eleftheria Koklanaris; Robert Q Le; Christopher S Hourigan; Bipin N Savani; Kamna Chawla; Sujata Shanbhag; A John Barrett; Minoo Battiwalla
Journal:  Exp Hematol       Date:  2013-10-17       Impact factor: 3.084

5.  Partial lipodystrophy in patients who have undergone hematopoietic stem cell transplantation during childhood: an institutional cross-sectional survey.

Authors:  Masanori Adachi; Yuji Oto; Koji Muroya; Junko Hanakawa; Yumi Asakura; Hiroaki Goto
Journal:  Clin Pediatr Endocrinol       Date:  2017-04-22

Review 6.  Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability.

Authors:  Moisés Ó Fiesco-Roa; Benilde García-de Teresa; Paula Leal-Anaya; Renée van 't Hek; Talia Wegman-Ostrosky; Sara Frías; Alfredo Rodríguez
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

Review 7.  Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells.

Authors:  Francesco Orio; Giovanna Muscogiuri; Stefano Palomba; Bianca Serio; Mariarosaria Sessa; Valentina Giudice; Idalucia Ferrara; Libuse Tauchmanovà; Annamaria Colao; Carmine Selleri
Journal:  ScientificWorldJournal       Date:  2014-04-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.